Literature DB >> 23463199

Hepatitis C virus proteins: from structure to function.

Darius Moradpour1, François Penin.   

Abstract

Great progress has been made over the past years in elucidating the structure and function of the hepatitis C virus (HCV) proteins, most of which are now actively being pursued as antiviral targets. The structural proteins, which form the viral particle, include the core protein and the envelope glycoproteins E1 and E2. The nonstructural proteins include the p7 viroporin, the NS2 protease, the NS3-4A complex harboring protease and NTPase/RNA helicase activities, the NS4B and NS5A proteins, and the NS5B RNA-dependent RNA polymerase. NS4B is a master organizer of replication complex formation while NS5A is a zinc-containing phosphoprotein involved in the regulation of HCV RNA replication versus particle production. Core to NS2 make up the assembly module while NS3 to NS5B represent the replication module (replicase). However, HCV proteins exert multiple functions during the viral life cycle, and these may be governed by different structural conformations and/or interactions with viral and/or cellular partners. Remarkably, each viral protein is anchored to intracellular membranes via specific determinants that are essential to protein function in the cell. This review summarizes current knowledge of the structure and function of the HCV proteins and highlights recent advances in the field.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23463199     DOI: 10.1007/978-3-642-27340-7_5

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  118 in total

Review 1.  The ins and outs of hepatitis C virus entry and assembly.

Authors:  Brett D Lindenbach; Charles M Rice
Journal:  Nat Rev Microbiol       Date:  2013-09-10       Impact factor: 60.633

2.  Apolipoprotein E likely contributes to a maturation step of infectious hepatitis C virus particles and interacts with viral envelope glycoproteins.

Authors:  Ji-Young Lee; Eliana G Acosta; Ina Karen Stoeck; Gang Long; Marie-Sophie Hiet; Birthe Mueller; Oliver T Fackler; Stephanie Kallis; Ralf Bartenschlager
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

Review 3.  Picornavirus morphogenesis.

Authors:  Ping Jiang; Ying Liu; Hsin-Chieh Ma; Aniko V Paul; Eckard Wimmer
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

4.  Encoded library technology screening of hepatitis C virus NS4B yields a small-molecule compound series with in vitro replicon activity.

Authors:  Christopher Arico-Muendel; Zhengrong Zhu; Hamilton Dickson; Derek Parks; Jesse Keicher; Jianghe Deng; Leah Aquilani; Frank Coppo; Todd Graybill; Kenneth Lind; Andrew Peat; Michael Thomson
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

5.  Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C Virus.

Authors:  Thibaut Vausselin; Karin Séron; Muriel Lavie; Ahmed Atef Mesalam; Matthieu Lemasson; Sandrine Belouzard; Lucie Fénéant; Adeline Danneels; Yves Rouillé; Laurence Cocquerel; Lander Foquet; Arielle R Rosenberg; Czeslaw Wychowski; Philip Meuleman; Patricia Melnyk; Jean Dubuisson
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

Review 6.  Approved Antiviral Drugs over the Past 50 Years.

Authors:  Erik De Clercq; Guangdi Li
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

7.  B-cell receptors expressed by lymphomas of hepatitis C virus (HCV)-infected patients rarely react with the viral proteins.

Authors:  Patrick P Ng; Chiung-Chi Kuo; Stanley Wang; Shirit Einav; Luca Arcaini; Marco Paulli; Carol S Portlock; Joseph Marcotrigiano; Alexander Tarr; Jonathan Ball; Ronald Levy; Shoshana Levy
Journal:  Blood       Date:  2014-01-21       Impact factor: 22.113

8.  Substitutions at NS3 Residue 155, 156, or 168 of Hepatitis C Virus Genotypes 2 to 6 Induce Complex Patterns of Protease Inhibitor Resistance.

Authors:  Sanne B Jensen; Stéphanie B N Serre; Daryl G Humes; Santseharay Ramirez; Yi-Ping Li; Jens Bukh; Judith M Gottwein
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

9.  Hepatitis C Virus NS4B Can Suppress STING Accumulation To Evade Innate Immune Responses.

Authors:  Guanghui Yi; Yahong Wen; Chang Shu; Qingxia Han; Kouacou V Konan; Pingwei Li; C Cheng Kao
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

Review 10.  The yin and yang of hepatitis C: synthesis and decay of hepatitis C virus RNA.

Authors:  You Li; Daisuke Yamane; Takahiro Masaki; Stanley M Lemon
Journal:  Nat Rev Microbiol       Date:  2015-08-10       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.